Notwithstanding these limitations, the observation that TGF-β1 induces profound changes in cellular metabolism during renal fibroblast activation, in part via regulatory effects centred on PDC, provides new insight into our understanding of TGF-β1 signalling and an opportunity to develop new approaches for preventing fibrosis in CKD. This evidence concerns the gene TGFB1 and chronic kidney disease.